Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.Learn more about our company
Visions and Values
Sandoz is the first company to receive approval of a biosimilar in the US.
March 31, 2015
Sandoz today announced the US market introduction of amlodipine and valsartan combination tablets, a generic version of EXFORGE® made by Novartis....
Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.Learn more about careers at Sandoz
Watch our videos to discover more about the world of Sandoz and the generics market.Visit our video gallery to watch the latest episode